Unichem pays EUR 16.75 million fine in Perindopril drug matter

Regulatory & Legal View source PDF Explain this filing

UNICHEMLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.2%Reaction day

₹468.95

prior close

₹461.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.5%-0.2% vs market

Pharmaceuticals peers, median of 154sector+0.4%-0.2% vs sector

On the reaction day the stock moved 0.2 pts less than Nifty Microcap 250 and 0.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+2.6

10m

+2.6

15m

+2.1

30m

+3.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.2+0.5-0.2+0.4-0.2

Next day

+1.3+0.3+1.0+0.1+1.1

+0.9-0.1+0.9-0.3+1.1

+1.1+1.0+0.1+0.8+0.2

+0.3+0.2+0.0+0.0+0.3

+0.7-1.5+2.1-1.3+2.0

-2.7-1.5-1.3-2.0-0.7

15d

+1.9-1.7+3.6-3.0+4.9

-1.9-3.1+1.2-2.9+1.0

-5.6-6.6+1.0-5.8+0.2

-21.7-12.3-9.5-11.2-10.5

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 154Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Unichem Laboratories said it paid the European Commission a fine of EUR 16,753,873.41, including interest, in the Perindopril drug matter. The payment follows earlier disclosures dated 27 June 2024 and 18 September 2025.

Likely market impact

The payment reduces cash by EUR 16.75 million and confirms a cost related to the Perindopril case. No SEBI action is disclosed.